Side negotiation by the US, EU, South Africa and India to waive patent protections. Critics say its not broad enough because pharma companies still get compensation and there are tracking requirements. China is excluded from the suspension. Needs a consensus in the WTO. UK/Switzerland as major exporters are likely opposed. Biden's support is a surprise.